Autobahn Therapeutics, Inc.

This study is testing if adding an investigational drug called ABX-002 to a person's current mood-stabilizing medications can help reduce symptoms of depression in adults with bipolar disorder. It will enroll about 30 people experiencing a depressive episode and will use brain sc…

This study is testing whether adding an investigational drug called ABX-002 to a person's current antidepressant helps reduce depression symptoms. It will involve about 230 adults with moderate to severe depression who haven't gotten enough relief from their current medication al…